ReCode Therapeutics Employee Directory
Biotechnology ResearchNorth Carolina, United States51-200 Employees
ReCode Therapeutics is a clinical-stage biotechnology company based in Durham, North Carolina, focused on developing genetic medicines. It seeks to enable selective targeting of organs and cells beyond the liver for mRNA and gene-correction therapies through an advanced delivery approach. The core objective is to broaden the reach and precision of genetic medicines by enabling tissue-specific delivery. In the biotechnology research sector, the company positions itself as a provider of delivery solutions that support researchers and developers working on genetic medicines. A recent milestone is the May 2026 presentation of clinical data from its inhaled mRNA program, RCT1100, at the American Thoracic Society conference.